The global antibody production market was valued at $12.3 billion in 2022, and is projected to reach $29.4 billion by 2032, growing at a CAGR of 9.1% from 2023 to 2032.
The global viral vector production market was valued at $1.1 billion in 2022, and is projected to reach $6.1 billion by 2032, growing at a CAGR of 18.8% from 2023 to 2032.
